A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Disorder on an Optimal Dose of SSRIs: A Randomized Controlled Trial in Iran

Abstract

This study compared the effects of adding acceptance and commitment therapy (ACT) or exposure and response prevention (ERP) to adults diagnosed with obsessive compulsive disorder (OCD) already on an optimal and stable dose of selective serotonin reuptake inhibitors (SSRIs). Forty adults on SSRIs who were diagnosed with OCD participated in a randomized controlled trial in Iran of 12 individual weekly sessions of either ACT+SSRI, ERP+SSRI, or continued SSRI only. The results showed significant reductions in OCD symptom severity in ACT+SSRI and ERP+SSRI conditions at posttreatment with significantly greater reductions in both conditions compared to SSRI-only at follow-up. Additionally, psychological inflexibility and use of thought control strategies significantly decreased in the ACT+SSRI condition at posttreatment and follow-up compared to the ERP+SSRI and SSRI conditions. Both conditions led to decreases in perceived importance of stop signals. Results provide cross-cultural support for the treatment of OCD using ACT and ERP as adjuncts to SSRI and modest process of change differences between ACT and ERP. Future directions and study limitations are discussed.

Keywords

obsessive-compulsive disorder acceptance and commitment therapy exposure and response prevention selective serotonin reuptake inhibitors psychological flexibility

Get full access to this article

View all access options for this article.

References

Abramowitz

J. S.

(2017). The nature and treatment of obsessions and compulsions. In McKay

Abramowitz

J.S.

Storch

E. A.

(Eds.), Treatments for psychological problems and syndromes. Wiley-Blackwell.

Abramowitz

J. S.

Taylor

McKay

(2009). Obsessive-compulsive disorder. The Lancet, 374(9688), 491–499.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.

Arch

J. J.

Eifert

G. H.

Davies

Vilardaga

J. C. P.

Rose

R. D.

Craske

M. G.

(2012). Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders. Journal of Consulting and Clinical Psychology, 80(5), 750–765. https://doi.org/10.1037/a0028310

A-Tjak

J. G. L.

Davis

M. L.

Morina

Powers

M. B.

Smits

J. A. J.

Emmelkamp

P. M. G.

(2015). A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychotherapy and Psychosomatics, 84(1), 30–36.

Baghooli

Dolatshahi

Mohammadkhani

Moshtagh

Naziri

(2014). Effectiveness of acceptance and commitment therapy in reduction of severity symptoms of patients with obsessive–compulsive disorder. Advances in Environmental Biology, 8(7), 2519–2525.

Ballenger

J. C.

(1999). Current treatments of the anxiety disorders in adults. Biological Psychiatry, 46(11), 1579–1594.

Bates

Maechler

Bolker

Walker

(2015). Fitting linear mixed-effects models using lme4. Journal of Statistical Software, 67(1), 1–48. https://doi.org/10.18637/jss.v067.i01

Bluett

E. J.

Homan

K. J.

Morrison

K. L.

Levin

M. E.

Twohig

M. P.

(2014). Acceptance and commitment therapy for anxiety and OCD spectrum disorders: An empirical review. Journal of Anxiety Disorders, 28(6), 612–624.

10.

Bond

F. W.

Hayes

S. C.

Baer

R. A.

Carpenter

K. M.

Guenole

Orcutt

H. K.

Waltz

Zettle

R. D.

(2011). Preliminary psychometric properties of the acceptance and action questionnaire–II: A revised measure of psychological inflexibility and experiential avoidance. Behavior Therapy, 42(4), 676–688.

11.

Craske

M. G.

Niles

A. N.

Burklund

L. J.

Wolitzky-Taylor

K. B.

Vilardaga

J. C.

Arch

J. J.

Saxbe

D. E.

Lieberman

M. D.

(2014). Randomized controlled trial of cognitive behavioral therapy and acceptance and commitment therapy for social phobia: Outcomes and moderators. Journal of Consulting and Clinical Psychology, 82(6), 1034–1048. https://doi.org/10.1037/a0037212

12.

du Mortier

J. A.

Visser

H. A.

van Balkom

A. J.

van Megen

H. J.

Hoogendoorn

A. W.

Glas

van Oppen

. (2019). Examining the factor structure of the self-report Yale-Brown Obsessive Compulsive Scale Symptom Checklist. Psychiatry Research, 271, 299–305.

13.

First

M. B.

Williams

J. B.

(2016). SCID-5-CV: Structured Clinical Interview for DSM-5 Disorders: Clinician Version. American Psychiatric Association Publishing.

14.

Foa

E. B.

Kozak

M. J.

(2004). Mastery of obsessive-compulsive disorder: A cognitive- behavioral approach: Oxford University Press.

15.

Foa

E. B.

McLean

C. P.

(2016). The efficacy of exposure therapy for anxiety-related disorders and its underlying mechanisms: The case of OCD and PTSD. Annual Review of Clinical Psychology, 12, 1–28.

16.

Foa

E. B.

Yadin

Lichner

T. K.

(2012). Treating your OCD with exposure and response (ritual) prevention workbook: Oxford University Press.

17.

Franklin

M. E.

Abramowitz

J. S.

Bux

D. A.

Jr. Zoellner

L. A.

Feeny

N. C.

(2002). Cognitive-behavioral therapy with and without medication in the treatment of obsessive- compulsive disorder. Professional Psychology: Research and Practice, 33(2), 162–168.

18.

Ghassemzadeh

Mojtabai

Khamseh

Ebrahimkhani

Issazadegan

A. A.

Saif-Nobakht

(2002). Symptoms of obsessive-compulsive disorder in a sample of Iranian patients. International Journal of Social Psychiatry, 48(1), 20–28.

19.

Goodman

W. K.

Price

L. H.

Rasmussen

S. A.

Mazure

Delgado

Heninger

G. R.

Charney

D. S.

(1989). The Yale-Brown obsessive compulsive scale: Validity. Archives of General Psychiatry, 46(11), 1012–1016.

20.

Grassi

Pallanti

(2018). Current and up-and-coming pharmacotherapy for obsessive- compulsive disorder in adults. Expert Opinion on Pharmacotherapy, 19(14), 1541–1550.

21.

Haaland

Å. T.

Eskeland

S. O.

Moen

E. M.

Vogel

P. A.

Haseth

Mellingen

Himle

J. A.

Woods

D. W.

Hummelen

. (2017). ACT-enhanced behavior therapy in group format for trichotillomania: An effectiveness study. Journal of Obsessive-Compulsive and Related Disorders, 12, 109–116.

22.

Hauschildt

Dar

Schröder

Moritz

(2019). Congruence and discrepancy between self-rated and clinician-rated symptom severity on the Yale–Brown Obsessive- Compulsive Scale (Y-BOCS) before and after a low-intensity intervention. Psychiatry Research, 273, 595–602.

23.

Hayes

S. C.

Luoma

J. B.

Bond

F. W.

Masuda

Lillis

(2006). Acceptance and commitment therapy: Model, processes and outcomes. Behaviour Research and Therapy, 44(1), 1–25.

24.

Hayes

S. C.

Strosahl

K. D.

Wilson

K. G.

(2012). Acceptance and commitment therapy: The process and practice of mindful change (2nd ed.). Guilford Press.

25.

Hirschfeld

(2003). Long-term side effects of SSRIs: Sexual dysfunction and weight gain. The Journal of Clinical Psychiatry, 64, 20–24.

26.

Hofmann

S. G.

Hayes

S. C.

(2019). The future of intervention science: Process-based therapy. Clinical Psychological Science, 7(1), 37–50. https://doi.org/10.1177/2167702618772296

27.

Hox

J. J.

Moerbeek

Van de Schoot

(2017). Multilevel analysis: Techniques and applications. Routledge.

28.

Kampman

Keijsers

Hoogduin

Verbraak

(2002). Addition of cognitive- behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatrica Scandinavica, 106(4), 314–319.

29.

Leifeld

(2013). texreg: Conversion of statistical model output in R to LaTeX and HTML tables. Journal of Statistical Software, 55(8), 1–24. https://doi.org/10.18637/jss.v055.i08

30.

Loerinc

A. G.

Meuret

A. E.

Twohig

M. P.

Rosenfield

Bluett

E. J.

Craske

M. G.

(2015). Response rates for CBT for anxiety disorders: Need for standardized criteria. Clinical Psychology Review, 42, 72–82.

31.

Mancebo

M. C.

Eisen

J. L.

Pinto

Greenberg

B. D.

Dyck

I. R.

Rasmussen

S. A.

(2006). The Brown longitudinal obsessive compulsive study: Treatments received and patient impressions of improvement. The Journal of Clinical Psychiatry, 67(11), 1713–1720.

32.

Math

Janardhan Reddy

(2007). Issues in the pharmacological treatment of obsessive– compulsive disorder. International Journal of Clinical Practice, 61(7), 1188–1197.

33.

McKay

Sookman

Neziroglu

Wilhelm

Stein

D. J.

Kyrios

Matthews

Veale

(2015). Efficacy of cognitive-behavioral therapy for obsessive–compulsive disorder. Psychiatry Research, 225(3), 236–246.

34.

Middleton

Wheaton

M. G.

Kayser

Simpson

H. B.

(2019). Treatment resistance in obsessive-compulsive disorder. In Treatment resistance in psychiatry (pp. 165–177). Springer.

35.

Moret

Isaac

Briley

(2009). Problems associated with long-term treatment with selective serotonin reuptake inhibitors. Journal of Psychopharmacology, 23(8), 967–974.

36.

Mohammadi

M. R.

Ghanizadeh

Rahgozar

Noorbala

A. A.

Davidian

Afzali

H. M.

, et al. (2004). Prevalence of obsessive-compulsive disorder in Iran. BMC Psychiatry, 4(1), 2. https://doi.org/10.1186/1471-244X-4-2.

37.

Myers

S. G.

Fisher

P. L.

Wells

(2009). An empirical test of the metacognitive model of obsessive-compulsive symptoms: Fusion beliefs, beliefs about rituals, and stop signals. Journal of Anxiety Disorders, 23(4), 436–442.

38.

Myers

S. G.

Grøtte

Haseth

Guzey

I. C.

Hansen

Vogel

P. A.

Solem

(2017). The role of metacognitive beliefs about thoughts and rituals: A test of the metacognitive model of obsessive-compulsive disorder in a clinical sample. Journal of Obsessive- Compulsive and Related Disorders, 13, 1–6. https://doi.org/10.1016/j.jocrd.2017.01.007

39.

Olatunji

B. O.

Davis

M. L.

Powers

M. B.

Smits

J. A.

(2013). Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators. Journal of Psychiatric Research, 47(1), 33–41.

40.

Ong

C. W.

Clyde

J. W.

Bluett

E. J.

Levin

M. E.

Twohig

M. P.

(2016). Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say? Journal of Anxiety Disorders, 40, 8–17.

41.

Osland

Arnold

P. D.

Pringsheim

(2018). The prevalence of diagnosed obsessive compulsive disorder and associated comorbidities: A population-based Canadian study. Psychiatry Research, 268, 137–142.

42.

Öst

L.-G.

Havnen

Hansen

Kvale

(2015). Cognitive behavioral treatments of obsessive–compulsive disorder. A systematic review and meta-analysis of studies published 1993–2014. Clinical Psychology Review, 40, 156–169.

43.

Pigott

T. A.

Seay

S. M.

(1999). A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Journal of Clinical Psychiatry, 60(2), 101–106.

44.

Polman

Bouman

T. K.

van Hout

W. J.

de Jong

P. J.

den Boer

J. A.

(2010). Processes of change in cognitive–behavioural treatment of obsessive–compulsive disorder: Current status and some future directions. Clinical Psychology & Psychotherapy: An International Journal of Theory & Practice, 17(1), 1–12.

45.

R Core Team. (2018). R: A language and environment for statistical computing. R Foundation for Statistical Computing.

46.

Reynolds

Wells

(1999). The thought control questionnaire–psychometric properties in a clinical sample, and relationships with PTSD and depression. Psychological Medicine, 29(5), 1089–1099.

47.

Rohani

Rasouli-Azad

Twohig

M. P.

Ghoreishi

F. S.

Lee

E. B.

Akbari

(2018). Preliminary test of group acceptance and commitment therapy on obsessive-compulsive disorder for patients on optimal dose of selective serotonin reuptake inhibitors. Journal of Obsessive-Compulsive and Related Disorders, 16, 8–13.

48.

RStudio Team. (2015). RStudio: Integrated development for R. RStudio, Inc. http://www.rstudio.com/

49.

Sabahi

Sepehri

Mohsenbeigi

Sepehri

(2014). Patterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in Kerman province, Iran. Sultan Qaboos University Medical Journal, 14(3), e382.

50.

Sayyah

Rahim

(2018). Pharmacotherapy for treatment-respondent vs. refractory obsessive–compulsive disorder in children and adults: Strategies, meta-analyses and clinical guidelines. Archives of Psychiatry and Psychotherapy, 3, 42–54.

51.

Schulz

K. F.

Altman

D. G.

Moher

(2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Medicine, 8(1), 18.

52.

Shabani

M. J.

Mohsenabadi

Omidi

Lee

E. B.

Twohig

M. P.

Ahmadvand

Zanjani

(2019). An Iranian study of group acceptance and commitment therapy versus group cognitive behavioral therapy for adolescents with obsessive-compulsive disorder on an optimal dose of selective serotonin reuptake inhibitors. Journal of Obsessive- Compulsive and Related Disorders, 22, 100440. https://doi.org/10.1016/j.jocrd.2019.04.003

53.

Simpson

H. B.

Foa

E. B.

Liebowitz

M. R.

Ledley

D. R.

Huppert

J. D.

Cahill

Vermes

Schmidt

A. B.

Hembree

Franklin

Campeas

Hahn

C. G.

Petkova

(2008). A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. American Journal of Psychiatry, 165(5), 621–630.

54.

Soomro

G. M.

Altman

Rajagopal

Oakley-Browne

(2008). Selective serotonin re- uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Systematic Reviews, 2008(1), CD001765. https://doi.org/10.1002/14651858.CD001765.pub3

55.

Shankman

S. A.

Funkhouser

C. J.

Klein

D. N.

Davila

Lerner

Hee

(2018). Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM-5 (SCID). Int J Methods Psychiatr Res. 27:e1590. https://doi.org/10.1002/mpr.1590

56.

Steketee

Frost

Bogart

(1996). The Yale-Brown obsessive compulsive scale: Interview versus self-report. Behaviour Research and Therapy, 34(8), 675–684.

57.

Tenneij

N. H.

van Megen

H. J.

Denys

D. A.

Westenberg

H. G.

(2005). Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. Journal of Clinical Psychiatry, 66(9), 1169–1175.

58.

Twohig

M. P.

Abramowitz

J. S.

Bluett

E. J.

Fabricant

L. E.

Jacoby

R. J.

Morrison

K. L.

Reuman

Smith

B. M.

(2015a). Exposure therapy for OCD from an acceptance and commitment therapy (ACT) framework. Journal of Obsessive-Compulsive and Related Disorders, 6, 167–173.

59.

Twohig

M. P.

Abramowitz

J. S.

Smith

B. M.

Fabricant

L. E.

Jacoby

R. J.

Morrison

K. L.

Bluett

E. J.

Reuman

Blakey

S. M.

Lederman

(2018). Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial. Behaviour Research and Therapy, 108, 1–9. https://doi.org/10.1016/j.brat.2018.06.005

60.

Twohig

M. P.

Hayes

S. C.

Plumb

J. C.

Pruitt

L. D.

Collins

A. B.

Hazlett-Stevens

Woidneck

M. R.

(2010). A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology, 78(5), 705–716.

61.

Twohig

M. P.

Ong

C. W.

Krafft

Barney

J. L.

Levin

M. E.

(2019). Starting off on the right foot in acceptance and commitment therapy. Psychotherapy, 56(1), 16–30.

62.

Twohig

M. P.

Vilardaga

J. C. P.

Levin

M. E.

Hayes

S. C.

(2015b). Changes in psychological flexibility during acceptance and commitment therapy for obsessive compulsive disorder. Journal of Contextual Behavioral Science, 4(3), 196–202.

63.

Twohig

M. P.

Woidneck

M. R.

Crosby

J. M.

(2013). Newer generations of CBT for anxiety disorders. In Simos

Hofmann

S. G.

(Eds.), CBT for anxiety disorders: A practitioner book (pp. 225–250): Wiley-Blackwell.

64.

Wells

Davies

M. I.

(1994). The thought control questionnaire: A measure of individual differences in the control of unwanted thoughts. Behaviour Research and Therapy, 32(8), 871–878.

65.

Wilke

C. O.

(2018). cowplot: Streamlined plot theme and plot annotations for ‘ggplot2’. https://CRAN.R-project.org/package=cowplot

66.

Zemestani

Abbarini

Castonguay

A. L.

(2019). Factor structure, validity, and reliability of a Persian version of the Body and Appearance Self-conscious Emotions Scale. Journal of Health Psychology, 135910531984292. https://doi.org/10.1177/1359105319842928

67.

Zemestani

Mozaffari

(2020). Acceptance and commitment therapy for the treatment of depression in persons with physical disability: A randomized controlled trial. Clinical Rehabilitation, 34(7), 938–947.